Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aurinia Pharmaceuticals Inc - Common Shares
(NQ:
AUPH
)
15.27
-0.01 (-0.07%)
Streaming Delayed Price
Updated: 9:33 AM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aurinia Pharmaceuticals Inc - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Tesla, Amazon, Apple, Aurinia Pharma, Vera Therapeutics: Why These 5 Stocks Are Drawing Investors' Attention Today
↗
January 03, 2023
Major Wall Street indices closed in the red on Tuesday, the first trading day of 2023, as concerns over rising rates and inflation still seem to drive investor sentiments.
Via
Benzinga
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 03, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces LUPKYNIS® (voclosporin) Patent Challenge Settlement Reached With Sun Pharmaceuticals
January 03, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Why Is Aurinia Pharmaceuticals (AUPH) Stock Down 30%?
↗
November 03, 2022
Despite strong Q3 earnings, shares of AUPH stock are in steep decline today after it lowered its full-year sales guidance.
Via
InvestorPlace
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 03, 2023
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Via
Benzinga
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis
November 30, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
↗
November 04, 2022
Aurinia Pharmaceuticals (NASDAQ:AUPH) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
November 03, 2022
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!
Via
InvestorPlace
Recap: Aurinia Pharmaceuticals Q3 Earnings
↗
November 03, 2022
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
↗
November 04, 2022
Upgrades
Via
Benzinga
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results
November 03, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
↗
November 04, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Via
Benzinga
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
↗
November 03, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.
Via
Benzinga
Earnings Preview For Aurinia Pharmaceuticals
↗
November 02, 2022
Aurinia Pharmaceuticals (NASDAQ:AUPH) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Aurinia Pharmaceuticals to Release Third Quarter 2022 Financial and Operational Results on November 3, 2022
October 28, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals Announces Presentations at American Society of Nephrology (ASN) Kidney Week 2022
October 27, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
↗
October 24, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
Via
Benzinga
Aurinia Pharmaceuticals Announces Presentations at American College of Rheumatology (ACR) Convergence 2022
September 20, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces European Commission Approval of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis
September 19, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
NASDAQ: AUPH Long Term Investor Alert: Investigation of Potential Wrongdoing at Aurinia Pharmaceuticals Inc.
↗
August 15, 2022
San Diego, CA -- (SBWIRE) -- 08/15/2022 -- Certain directors of Aurinia Pharmaceuticals Inc. are under investigation over possible breaches of fiduciary duties.
Via
SBWire
Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
↗
August 09, 2022
Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading.
Via
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
↗
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
August 04, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Why Aurinia Pharmaceuticals Stock Is Plunging
↗
July 26, 2022
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading lower Tuesday after the company received a notice regarding the U.S. Patent Office Patent Trial and Appeal Board's decision to institute...
Via
Benzinga
Aurinia Pharmaceuticals Notification Regarding Inter Partes Patent Review
July 26, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
↗
July 27, 2022
Wednesday saw 83 companies set new 52-week lows.
Via
Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
↗
July 27, 2022
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
